SELARL PHARMACIE DES CAPUCINS : revenue, balance sheet and financial ratios

SELARL PHARMACIE DES CAPUCINS is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in COMPIEGNE (60200), this company of category PME shows in 2019 a revenue of 2.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DES CAPUCINS (SIREN 828914473)
Indicator 2025 2024 2023 2022 2020 2019 2018
Revenue N/C N/C N/C N/C N/C 2 825 678 € 3 376 587 €
Net income 103 220 € 80 006 € 88 405 € 198 860 € 110 678 € 118 856 € 76 691 €
EBITDA N/C N/C N/C N/C N/C 163 126 € 95 742 €
Net margin N/C N/C N/C N/C N/C 4.2% 2.3%

Revenue and income statement

Im Jahr 2025 erzielt SELARL PHARMACIE DES CAPUCINS ein positives Nettoergebnis von 103 k€. Entwicklung 2018-2025: 77 k€ -> 103 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

103 220 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 3%. Dieses niedrige Niveau spiegelt eine solide Finanzstruktur wider. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 84%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

3.011%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

83.819%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

41.0%

Solvency indicators evolution
SELARL PHARMACIE DES CAPUCINS

Sector positioning

Verschuldungsgrad
3.01 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Ausgezeichnet

Im Jahr 2025 liegt in den unteren 25% der Branche, was positiv ist das verschuldungsgrad von SELARL PHARMACIE DES CAPU... (3.01). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Ein niedriges Verhältnis zeigt eine solide Finanzstruktur mit geringer Abhängigkeit von Gläubigern.

Finanzielle Autonomie
83.82% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Ausgezeichnet +9 pts over 3 years

Im Jahr 2025 liegt in den oberen 25% der Branche das finanzielle autonomie von SELARL PHARMACIE DES CAPU... (83.8%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Hohe Autonomie spiegelt finanzielle Unabhängigkeit und Fähigkeit wider, Schocks zu absorbieren.

Liquidity ratios

Die Liquiditätsquote beträgt 195.34. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

195.337

Liquidity indicators evolution
SELARL PHARMACIE DES CAPUCINS

Sector positioning

Liquiditätsquote
195.34 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Gut -11 pts over 3 years

Im Jahr 2025 liegt über dem Median der Branche das liquiditätsquote von SELARL PHARMACIE DES CAPU... (195.34). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Diese komfortable Position bietet eine nennenswerte Sicherheitsmarge.

Working capital requirement (WCR) and payment terms

Der Betriebskapitalbedarf (WCR) misst die zeitliche Lücke.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE DES CAPUCINS

Positioning of SELARL PHARMACIE DES CAPUCINS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE DES CAPUCINS is estimated at 1 639 661 € (range 1 112 682€ - 2 572 855€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1112k€ 1639k€ 2572k€
1 639 661 € Range: 1 112 682€ - 2 572 855€
NAF 5 année 2025

Valuation method used

Net Income Multiple
103 220 € × 15.9x = 1 639 662 €
Range: 1 112 682€ - 2 572 855€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DES CAPUCINS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DES CAPUCINS

What is the revenue of SELARL PHARMACIE DES CAPUCINS ?

The revenue of SELARL PHARMACIE DES CAPUCINS in 2019 is 2.8 M€.

Is SELARL PHARMACIE DES CAPUCINS profitable?

Yes, SELARL PHARMACIE DES CAPUCINS generated a net profit of 103 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE DES CAPUCINS ?

The headquarters of SELARL PHARMACIE DES CAPUCINS is located in COMPIEGNE (60200), in the department Oise.

Where to find the tax return of SELARL PHARMACIE DES CAPUCINS ?

The tax return of SELARL PHARMACIE DES CAPUCINS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DES CAPUCINS operate?

SELARL PHARMACIE DES CAPUCINS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.